As per MRFR analysis, the South America Brucellosis Market Size was estimated at 14.23 (USD Million) in 2023.The South America Brucellosis Market is expected to grow from 15.5(USD Million) in 2024 to 40.6 (USD Million) by 2035. The South America Brucellosis Market CAGR (growth rate) is expected to be around 9.148% during the forecast period (2025 - 2035).
Key South America Brucellosis Market Trends Highlighted
Numerous significant market factors are influencing the South American brucellosis market and reshaping its environment. The growing knowledge of zoonotic illnesses among consumers and health authorities is one important motivator.
Stronger laws and health initiatives to prevent brucellosis in livestock have resulted from this increased awareness, especially in nations like Brazil and Argentina where the livestock sector is essential to the national economy.
Additionally, increased funding for veterinary care and immunization campaigns is improving disease prevention and guaranteeing a strong response to outbreaks of brucellosis. The developing cattle industry and the rising demand for animal products present opportunities in the South American brucellosis market.
There is a push for better animal health and biosecurity controls as nations work toward sustainable farming methods. This tendency is especially apparent in areas where goat and cow rearing are common, giving market participants the chance to launch cutting-edge vaccines and diagnostic equipment.
Increasingly integrated approaches to disease management, combining vaccination with farmer education programs, have been increasingly prevalent in the South American brucellosis market in recent years. Training programs that teach optimal methods for handling livestock and animal health are being aggressively promoted by governments.
Additionally, in an effort to better understand the dynamics of brucellosis transmission, research partnerships involving public health organizations and commercial sector players are beginning to take shape.
In order to control and eventually lower the disease's prevalence, which promotes a healthier livestock population and increased food security throughout the region, such cooperative efforts are essential.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
South America Brucellosis Market Drivers
Growing Livestock Population
The livestock sector in South America has experienced a significant increase, which is a major driver for the South America Brucellosis Market. With countries like Brazil being one of the largest producers of beef and cattle globally, the livestock population plays a crucial role in the prevalence of zoonotic diseases such as brucellosis.
According to a recent report from the Brazilian Institute of Geography and Statistics, the livestock population in Brazil reached approximately 218 million head of cattle. This growing population is likely to contribute to higher incidences of brucellosis, thereby increasing the demand for vaccines and diagnostic tools to combat the disease.
Organizations such as the Food and Agriculture Organization of the United Nations (FAO) and the Pan American Health Organization (PAHO) emphasize the economic impact of brucellosis outbreaks in livestock, marking it as a public health concern. Thus, the expanding livestock sector is pivotal to understanding the growth trajectory of the South America Brucellosis Market.
Increased Awareness and Preventive Measures
There has been a growing awareness of brucellosis among farmers and the general public in South America, particularly in rural areas where livestock is a primary source of income. Initiatives led by health and agricultural departments in countries like Argentina and Colombia aim to educate farmers on the risks associated with brucellosis and the importance of vaccination programs.
According to the Ministry of Agriculture in Argentina, there has been a notable increase of up to 35% in vaccination coverage among livestock in recent years.
This heightened awareness translates into a rising demand for brucellosis vaccines and diagnostic tests, further propelling the South America Brucellosis Market. The collaboration with organizations such as the World Organization for Animal Health (OIE) helps bolster these preventive measures, promoting health and safeguarding the livelihoods of farmers.
Government Initiatives and Funding
Government policies aimed at controlling and preventing brucellosis outbreaks in livestock significantly influence the South America Brucellosis Market. Several countries in South America are implementing national strategic plans for the control of brucellosis.
For example, the Ministry of Agriculture in Brazil reported the allocation of over USD 5 million towards research and control programs for livestock diseases, including brucellosis.
Funding from governmental bodies aids in the development of vaccines, diagnostic tools, and public awareness campaigns, thus creating a conducive environment for the market's expansion. Multi-agency efforts also involve collaboration with the World Health Organization (WHO) to align animal health with public health, which further stimulates market growth.
Rising Incidence of Zoonotic Diseases
The increased prevalence of zoonotic diseases, including brucellosis, has become a pressing concern in South America. Zoonotic diseases, which can be transmitted from animals to humans, pose significant public health risks, particularly in rural communities that rely heavily on animal husbandry.
The World Health Organization (WHO) estimates that approximately 500,000 cases of brucellosis occur globally each year, with a significant proportion concentrated in developing countries like those in South America.
This alarming statistic underscores the need for enhanced disease management strategies, leading to an upsurge in demand for brucellosis vaccines and diagnostic testing. With national health organizations and governments prioritizing the control of zoonoses, the ramifications directly enhance the prospects of the South America Brucellosis Market.
South America Brucellosis Market Segment Insights
Brucellosis Market species Insights
The South America Brucellosis Market has shown a notable development concerning species segmentation, primarily focusing on Brucella suis, B. abortus, and B. melitensis. Among these species, B. abortus holds a prominent place as it primarily affects cattle, which are integral to the agricultural economy in South America.
The prevalence of this species has made it a critical target for disease management and control initiatives. Furthermore, the economic impact attributed to B. melitensis, which primarily affects sheep and goats, is significant as well, considering the importance of these livestock in the region's meat and dairy production.
The agricultural practices and livestock management in South America contribute to the presence of these pathogenic species, thereby underlining the necessity for robust vaccination and diagnostic strategies. B. suis, while less prevalent compared to the other two, remains noteworthy due to its impact on pigs, which are increasingly becoming important in various South American countries.
All three species indicate a growing concern among veterinarians and livestock owners regarding the economic burdens of brucellosis, which leads to production losses and trade restrictions. The complexity of controlling these brucellosis cases across species creates opportunities for innovative diagnostics and vaccines in the South American Brucellosis Market.
As the local governments and agricultural bodies continue to invest in disease prevention strategies, understanding the dynamics of these species becomes essential for addressing brucellosis-related challenges effectively. The rise of zoonotic diseases in the region has also pushed this agenda further, prompting a call for enhanced public health surveillance alongside veterinary health initiatives.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Brucellosis Market Regional Insights
The South America Brucellosis Market showcases significant growth potential, particularly within its Regional segment, encompassing Brazil, Mexico, Argentina, and the Rest of South America. Brazil stands as a crucial player in this market, with its large livestock population making it a key area for brucellosis management and control.
Mexico, too, has a noteworthy role due to its agricultural sector, which faces challenges from this disease, impacting both health and economic productivity. Argentina, with its extensive cattle farming industry, confronts the effects of brucellosis, thus prioritizing vaccine development and animal health initiatives.
The Rest of South America includes several countries where brucellosis remains a concern, prompting governments to enhance surveillance and preventive measures to safeguard livestock health.
The market dynamics in this region are influenced by various factors, such as rising concerns over animal health, increased investment in veterinary healthcare services, and collaboration among agricultural stakeholders for brucellosis eradication efforts.
The governmental policies aiming to mitigate disease outbreaks further emphasize the significance of this segment in ensuring food safety and economic stability across the region. Efforts to educate farmers about prevention and control methods also play a pivotal role in shaping the future of the South America Brucellosis Market, leading to improved livestock management practices.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
South America Brucellosis Market Key Players and Competitive Insights
The South America Brucellosis Market is characterized by its competitive landscape, primarily shaped by the presence of key players engaged in developing innovative vaccination solutions and diagnostic tests for brucellosis.
The market dynamics are influenced by the rising demand for effective control measures against the disease, which significantly impacts both livestock productivity and public health in the region.
A variety of companies are focusing on strengthening their market positions through strategic collaborations and advancements in research and development, aimed at providing comprehensive solutions tailored for local agricultural practices.
The market is also witnessing heightened regulatory scrutiny, encouraging firms to comply with stringent health guidelines while enhancing their product offerings to gain a competitive edge.
Elanco stands out in the South America Brucellosis Market due to its robust portfolio of animal health products specifically designed to combat infectious diseases. The company’s strengths lie in its commitment to research and the development of effective vaccines that cater to regional livestock needs.
Elanco's established presence in South America is further bolstered by its strong distribution networks and relationships with local farmers and veterinarians, allowing it to maintain a significant market share.
The focus on customer engagement and education regarding disease prevention strategies contributes to Elanco's reputable standing in the market, enabling it to respond effectively to the challenges posed by brucellosis outbreaks in various countries across the region.
Ceva Sante Animale plays a crucial role in the South America Brucellosis Market, offering a range of vaccines and diagnostic products aimed at preventing the spread of the disease among livestock. The company has successfully capitalized on its extensive research capabilities and localized strategies to create effective solutions that meet the needs of farmers in South America.
Ceva's strengths are reinforced by regular investments in innovative technologies and collaborations with local authorities, enhancing its ability to provide reliable products that address regional health concerns.
Additionally, Ceva Sante Animale has been active in pursuing mergers and acquisitions to expand its reach and strengthen its market position, solidifying its presence in the South American agricultural landscape and fostering partnerships that promote the adoption of its solutions for brucellosis control.
Key Companies in the South America Brucellosis Market Include
South America Brucellosis Market Developments
The South America Brucellosis Market is witnessing significant developments, marked by heightened awareness and control measures across the region. The Brazilian government has intensified vaccination campaigns against Brucellosis to enhance livestock health and productivity, leading to enhanced market stability.
Elanco continues to focus on the effectiveness of its vaccine solutions in combating livestock diseases, while Ceva Sante Animale is launching new brucellosis vaccination programs aimed at improving dairy cattle health in Argentina.
In terms of mergers and acquisitions, Zoetis announced the acquisition of a leading South American animal health company in July 2023, a move aimed at bolstering its position in the region's brucellosis market. Additionally, Boehringer Ingelheim's recent collaboration with local agricultural agencies in Colombia, reported in September 2023, highlights the company’s dedication to addressing livestock diseases.
The overall market value for companies like Merck Animal Health and Virbac has seen an upward trajectory due to increased livestock health initiatives, with a growing demand for effectively managing Brucellosis impacting the landscape of South America's animal health industry significantly.
South America Brucellosis Market Segmentation Insights
Brucellosis Market species Outlook
Brucellosis Market Regional Outlook
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2023 | 14.23(USD Million) |
| MARKET SIZE 2024 | 15.5(USD Million) |
| MARKET SIZE 2035 | 40.6(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 9.148% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Elanco, Ceva Sante Animale, Vetoquinol, Heska Corporation, Merck Animal Health, AgriLabs, Boehringer Ingelheim, Virbac, Cegelec, Zoetis, Hygieia |
| SEGMENTS COVERED | species, Regional |
| KEY MARKET OPPORTUNITIES | Increasing livestock vaccination programs, Rising awareness of zoonotic diseases, Expansion of diagnostic testing services, Government funding for disease control, Growth in veterinary healthcare services |
| KEY MARKET DYNAMICS | rising prevalence of livestock infections, increasing government funding for research, growing awareness of disease control, advancements in diagnostic technologies, expanding veterinary healthcare services |
| COUNTRIES COVERED | Brazil, Mexico, Argentina, Rest of South America |
Frequently Asked Questions (FAQ) :
The South America Brucellosis Market is expected to be valued at 15.5 million USD in 2024.
By 2035, the market is projected to grow and reach a value of 40.6 million USD.
The expected CAGR for the South America Brucellosis Market from 2025 to 2035 is 9.148%.
Brazil is projected to dominate the South America Brucellosis Market with an expected value of 12.5 million USD by 2035.
The market value for Brucella suis is expected to be 5.5 million USD in 2024 and 15.0 million USD in 2035.
The expected market size for B. abortus in 2024 is 6.0 million USD.
Key players in the South America Brucellosis Market include Elanco, Ceva Sante Animale, and Merck Animal Health, among others.
In 2024, the market value for Argentina in the South America Brucellosis Market is expected to be 4.0 million USD.
Challenges such as regulatory changes and disease management may affect the growth of the South America Brucellosis Market.
The projected market size for the Rest of South America by 2035 is expected to be 9.6 million USD.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
